Skip to main content

Table 1 The baseline characteristics of the study population

From: Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study

Parameters

FMT group

Control group

P value

Total number

10

10

–

Age(year), M ± SD (range)

51.5 ± 12.7 (32–70)

44.6 ± 14.9(22–75)

0.28

Gender, Female/Male

08-Feb

08-Feb

1.000

Disease duration (year)

5.9 ± 7.3 (0.5–25)

6.9 ± 9.3(0.3–30)

0.777

Disease severity

  

0.895

 Severe % (n)

50 (5/10)

40(4/10)

–

 Moderate % (n)

40 (4/10)

50(5/10)

–

 Mild % (n)

10 (1/10)

10(1/10)

–

Disease extent

  

1.000

 Pancolitis % (n)

50 (5/10)

50 (5/10)

–

 Left-sided colitis % (n)

50 (5/10)

50 (5/10)

–

Concomitant medications

–

 Mesalazine

90 (9/10)

100 (10/10)

–

 Allergy to 5-ASA

10(1/10)

–

–

Total Mayo score

9.5 ± 2.5

8.6 ± 2.9

0.462

Endoscopic Mayo score

2.4 ± 0.7

1.9 ± 0.7

0.137